Although data obtained here suggest that DSF–Cu may inhibit ALDH positive populations, further studies are needed (across a range of patient samples) to establish the extent of ALDH activity in GBM, and to evaluate the contribution of ALDH inhibition to GSC death. This evidence concerns the gene LDHA and glioblastoma.